Moreover, current studies have shown that DCH can reduce the activity levels of MMPs, particularly MMP2 and MMP9, in breast cancer, glioma, and oral squamous cell carcinoma [28, 41, 42]. This evidence concerns the gene MMP9 and breast carcinoma.